BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9926939)

  • 41. c-Jun binds the N terminus of human TAF(II)250 to derepress RNA polymerase II transcription in vitro.
    Lively TN; Ferguson HA; Galasinski SK; Seto AG; Goodrich JA
    J Biol Chem; 2001 Jul; 276(27):25582-8. PubMed ID: 11316804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloning and biochemical characterization of TAF-172, a human homolog of yeast Mot1.
    Chicca JJ; Auble DT; Pugh BF
    Mol Cell Biol; 1998 Mar; 18(3):1701-10. PubMed ID: 9488487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcription factor IID recruitment and Sp1 activation. Dual function of TAF1 in cyclin D1 transcription.
    Hilton TL; Wang EH
    J Biol Chem; 2003 Apr; 278(15):12992-3002. PubMed ID: 12569092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solution structure of a TBP-TAF(II)230 complex: protein mimicry of the minor groove surface of the TATA box unwound by TBP.
    Liu D; Ishima R; Tong KI; Bagby S; Kokubo T; Muhandiram DR; Kay LE; Nakatani Y; Ikura M
    Cell; 1998 Sep; 94(5):573-83. PubMed ID: 9741622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators.
    Chen JL; Attardi LD; Verrijzer CP; Yokomori K; Tjian R
    Cell; 1994 Oct; 79(1):93-105. PubMed ID: 7923382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins.
    Wang EH; Zou S; Tjian R
    Genes Dev; 1997 Oct; 11(20):2658-69. PubMed ID: 9334328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transactivation mediated by B-Myb is dependent on TAF(II)250.
    Bartusel T; Klempnauer KH
    Oncogene; 2003 May; 22(19):2932-41. PubMed ID: 12771944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1.
    Guermah M; Malik S; Roeder RG
    Mol Cell Biol; 1998 Jun; 18(6):3234-44. PubMed ID: 9584164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic dissection of hTAF(II)130 defines a hydrophobic surface required for interaction with glutamine-rich activators.
    Rojo-Niersbach E; Furukawa T; Tanese N
    J Biol Chem; 1999 Nov; 274(47):33778-84. PubMed ID: 10559271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The coactivator dTAF(II)110/hTAF(II)135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB.
    Felinski EA; Quinn PG
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13078-83. PubMed ID: 11687654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human Taf(II)130 is a coactivator for NFATp.
    Kim LJ; Seto AG; Nguyen TN; Goodrich JA
    Mol Cell Biol; 2001 May; 21(10):3503-13. PubMed ID: 11313476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo.
    Farmer G; Colgan J; Nakatani Y; Manley JL; Prives C
    Mol Cell Biol; 1996 Aug; 16(8):4295-304. PubMed ID: 8754830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway.
    Bouchard M; Giannakopoulos S; Wang EH; Tanese N; Schneider RJ
    J Virol; 2001 May; 75(9):4247-57. PubMed ID: 11287574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation of mouse TFIID and functional characterization of TBP and TFIID in mediating estrogen receptor and chromatin transcription.
    Wu SY; Thomas MC; Hou SY; Likhite V; Chiang CM
    J Biol Chem; 1999 Aug; 274(33):23480-90. PubMed ID: 10438527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclin D1 represses STAT3 activation through a Cdk4-independent mechanism.
    Bienvenu F; Gascan H; Coqueret O
    J Biol Chem; 2001 May; 276(20):16840-7. PubMed ID: 11279133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation.
    Verrier CS; Roodi N; Yee CJ; Bailey LR; Jensen RA; Bustin M; Parl FF
    Mol Endocrinol; 1997 Jul; 11(8):1009-19. PubMed ID: 9212049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TAF(II)250-independent transcription can be conferred on a TAF(II)250-dependent basal promoter by upstream activators.
    Weissman JD; Howcroft TK; Singer DS
    J Biol Chem; 2000 Apr; 275(14):10160-7. PubMed ID: 10744699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4.
    Wierstra I; Alves J
    Biol Chem; 2006 Jul; 387(7):949-62. PubMed ID: 16913845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TAF(II)250: a transcription toolbox.
    Wassarman DA; Sauer F
    J Cell Sci; 2001 Aug; 114(Pt 16):2895-902. PubMed ID: 11686293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Derepression of DNA damage-regulated genes requires yeast TAF(II)s.
    Li B; Reese JC
    EMBO J; 2000 Aug; 19(15):4091-100. PubMed ID: 10921889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.